Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
140.50    3.25 (2.36%)
Bid:
138.00
Ask:
144.50
Spread: 6.50 (4.71%)
Market Cap: £110.25m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Director/PDMR Shareholding

23 Apr 2020 14:35

RNS Number : 6939K
Xaar PLC
23 April 2020
 

Xaar plc (the "Company")

Director/PDMR Shareholding

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR CONNECTED PERSONS

This notification is made in accordance with the requirements of the Market Abuse Regulation

John Mills

The Company was notified on 23 April 2020 John Mills, Chief Executive Officer, has today acquired 125,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 39.3509 pence per Ordinary Share. Following this transaction, John Mills's beneficial interest in the Company is 125,000 Ordinary Shares representing 0.16% of the current issued share capital of the Company.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

John Mills

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Xaar Plc

b)

 

LEI

 

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

GB0001570810

b)

 

Nature of the transaction

 

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

39.3509p

125,000

d)

 

Aggregated information

- Aggregated volume

125,000

- Price

39.3509p

e)

 

Date of the transaction

 

 

23 April 2020

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

Ian Tichias

The Company was notified on 23 April 2020 Ian Tichias, Chief Finance Officer, has today acquired 50,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 39.3509 pence per Ordinary Share. Following this transaction, Ian Tichias beneficial interest in the Company is 50,000 Ordinary Shares representing 0.064% of the current issued share capital of the Company.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Ian Tichias

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Finance Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Xaar Plc

b)

 

LEI

 

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

GB0001570810

b)

 

Nature of the transaction

 

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

39.3509p

50,000

d)

 

Aggregated information

- Aggregated volume

50,000

- Price

39.3509p

e)

 

Date of the transaction

 

 

23 April 2020

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

Andrew Herbert

The Company was notified on 23 April 2020 Andrew Herbert, Chairman, has today acquired 100,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 39.3509 pence per Ordinary Share. Following this transaction, Andrew Herbert's beneficial interest in the Company is 100,000 Ordinary Shares representing 0.13% of the current issued share capital of the Company.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Andrew Herbert

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chairman

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Xaar Plc

b)

 

LEI

 

 

213800MXEC3KAOBBPO57

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

GB0001570810

b)

 

Nature of the transaction

 

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

39.3509p

100,000

d)

 

Aggregated information

- Aggregated volume

100,000

- Price

39.3509p

e)

 

Date of the transaction

 

 

23 April 2020

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

Enquiries:

Xaar plc

+44 (0) 1223 423 663

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFVVSVIVFII
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.